First Study in Humans With GSK206136

NCT01059578 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

33

Enrollment

INDUSTRY

Sponsor class

Conditions

Depressive Disorder and Anxiety Disorders

Interventions

DRUG: GSK206136
DRUG: PLACEBO
RADIATION: PET

Sponsor

GlaxoSmithKline